The Role of Antiviral Treatment of Influenza in Reducing Hospitalizations and Other Severe Outcomes: A Need for More Evidence
Abstract More evidence is needed to define the benefits and role of antiviral treatment to reduce risk of severe influenza outcomes based on clinical risk factors and timing. Well-conducted real-world observational studies can complement evidence from randomized controlled trials to address critical gaps.
Authors
- Timothy M. Uyeki (ORCID: https://orcid.org/0000-0001-5338-8668)
- Mark W. Tenforde (ORCID: https://orcid.org/0000-0002-8702-8393)
- Jessie R. Chung (ORCID: https://orcid.org/0000-0001-5205-966X)
- Katherine Adams (ORCID: https://orcid.org/0000-0002-1818-1730)
- Shikha Garg (ORCID: https://orcid.org/0009-0004-3493-2989)
Institutions
- Centers for Disease Control and Prevention (US)
- National Center for Immunization and Respiratory Diseases (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1093/infdis/jiaf573
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00